(Q51573949)

7 April 2018

title

Treatment results of radiation therapy for muscle-invasive bladder cancer. (English)

1 reference

7 April 2018

adaptive radiation therapy

main subject

0 references

author name string

Tanja Langsenlehner

1

1 reference

7 April 2018

Carmen Döller

2

1 reference

7 April 2018

Franz Quehenberger

3

1 reference

7 April 2018

Heidi Stranzl-Lawatsch

4

1 reference

7 April 2018

Uwe Langsenlehner

5

1 reference

7 April 2018

Karl Pummer

6

1 reference

7 April 2018

Karin S Kapp

7

1 reference

7 April 2018

publication date

26 March 2010

1 reference

7 April 2018

Strahlentherapie und Onkologie

published in

1 reference

7 April 2018

volume

186

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

203-209

1 reference

7 April 2018

Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Adaptive radiotherapy for invasive bladder cancer: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Combined modality treatment with bladder preservation for muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Radiotherapy with and without cisplatin in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2053-1

Bladder preservation: optimizing radiotherapy and integrated treatment strategies

21 January 2018

1 reference

12 December 2020

Outcomes of radical cystectomy

1 reference

12 December 2020

External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients

1 reference

12 December 2020

Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results

1 reference

12 December 2020

Image-guided radiotherapy of bladder cancer: bladder volume variation and its relation to margins.

1 reference

12 December 2020

Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.

1 reference

12 December 2020

Organ-sparing treatment in muscle-invasive bladder cancer

1 reference

12 December 2020

Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy

1 reference

12 December 2020

Trimodality treatment and selective organ preservation for bladder cancer

1 reference

12 December 2020

Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients.

1 reference

12 December 2020

Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer

1 reference

12 December 2020

Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arc

1 reference

12 December 2020

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

1 reference

12 December 2020

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch

1 reference

12 December 2020

[Radiation treatment of bladder cancer using different fractionation regimens]

1 reference

12 December 2020

Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth

1 reference

12 December 2020

Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial

1 reference

12 December 2020

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

12 December 2020

Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience

1 reference

12 December 2020

Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter

1 reference

12 December 2020

Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure

1 reference

12 December 2020

Current status of radiation therapy and combined-modality treatment for bladder cancer

1 reference

12 December 2020

The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy.

1 reference

12 December 2020

Complications following radical cystectomy for bladder cancer in the elderly

1 reference

12 December 2020

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation

1 reference

12 December 2020

Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study

1 reference

12 December 2020

Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas

1 reference

12 December 2020

Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?

1 reference

12 December 2020

Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy

1 reference

12 December 2020

Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

1 reference

12 December 2020

Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy

1 reference

12 December 2020

Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Surgery versus radiotherapy for muscle invasive bladder cancer

1 reference

12 December 2020

Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer

1 reference

12 December 2020

Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer

1 reference

12 December 2020

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS

1 reference

12 December 2020

Laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach

1 reference

12 December 2020

Bladder-sparing approaches to invasive disease

1 reference

12 December 2020

Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques.

1 reference

12 December 2020

Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer

1 reference

12 December 2020

Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series

1 reference

12 December 2020

"Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.

1 reference

12 December 2020

Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial

1 reference

12 December 2020

10.1007/S00066-010-2053-1

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018